Grown Rogue International Inc. (GRUSF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Grown Rogue International Inc. (GRUSF) trades at $0.47 with AI Score 43/100 (Grade C). Grown Rogue International Inc. cultivates and sells cannabis products in the United States, offering a range of flower, edibles, and concentrates through dispensaries. Market cap: $117.67M, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for GRUSF: GRUSF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GRUSF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
GRUSF: the 1 perspectives are evenly split.
How is this calculated? →Grown Rogue International Inc. (GRUSF) Healthcare & Pipeline Overview
Grown Rogue International Inc. focuses on the U.S. cannabis market, offering diverse products like flower, edibles, and concentrates. With a 28.8% profit margin and a presence in dispensaries, the company navigates the complexities of a rapidly growing yet heavily regulated industry.
What Is the Investment Thesis for GRUSF?
Grown Rogue International Inc. presents a unique investment proposition within the cannabis sector, characterized by a $117.67M market cap and a P/E ratio of 12.53. The company's strong profit margin of 28.8% and gross margin of 49.8% indicate efficient operations. Key growth catalysts include expanding its product offerings and distribution network. However, the company's beta of -1.31 suggests a high level of volatility. Investors may want to evaluate the risks associated with operating in a highly regulated industry and the potential for changing consumer preferences. The absence of a dividend yield may deter some investors seeking income. The company's ability to navigate regulatory hurdles and capitalize on market opportunities will be crucial for long-term success.
Based on FMP financials and quantitative analysis
GRUSF Key Highlights
- Market Cap of $117.67M indicates Grown Rogue International Inc. is a small-cap company with potential for growth.
- P/E ratio of 12.53 suggests the company may be undervalued compared to its earnings.
- Profit Margin of 28.8% demonstrates strong profitability compared to industry peers.
- Gross Margin of 49.8% reflects efficient cost management in production and sales.
- Beta of -1.31 indicates the stock price is less sensitive to market movements, potentially offering stability in volatile times.
Who Are GRUSF's Competitors?
GRUSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BIOYF BioSyent Inc. | $10.31 | +1.28% | $117.93M | 50 |
| ETST Earth Science Tech, Inc. | $0.17 | +25.56% | $48.85M | 61 |
| IUGNF Imugene Limited | $0.06 | -25.00% | $24.95M | 41 |
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GRUSF's Key Strengths?
- Diverse product offerings (flower, edibles, concentrates).
- Established distribution network through dispensaries.
- Strong profit margin of 28.8%.
- Gross margin of 49.8% indicates efficient operations.
What Are GRUSF's Weaknesses?
- Small market capitalization of $117.67M.
- High beta of -1.31 suggests volatility.
- Reliance on a single geographic market (United States).
- No dividend yield may deter some investors.
What Could Drive GRUSF Stock Higher?
- Potential expansion into new states as cannabis legalization progresses.
- Increasing demand for diverse cannabis products, such as edibles and concentrates.
- Strategic partnerships with dispensaries to enhance distribution network.
What Are the Key Risks for GRUSF?
- Stringent and evolving regulations in the cannabis industry.
- Intense competition from other cannabis companies.
- Changing consumer preferences and trends.
- Federal legalization could disrupt the market.
- Limited financial disclosure due to OTC listing.
What Are the Growth Opportunities for GRUSF?
- Expanding Product Offerings: Grown Rogue can capitalize on the growing demand for diverse cannabis products by introducing new edibles, vape cartridges, and concentrates. The edibles market, in particular, is experiencing rapid growth, with projections estimating a market size of $4.1 billion by 2028. By innovating and expanding its product line, Grown Rogue can attract new customers and increase its market share. This expansion can be achieved within the next 1-2 years.
- Geographic Expansion: As more states legalize cannabis, Grown Rogue has the opportunity to expand its operations into new markets. Focusing on states with favorable regulatory environments and strong consumer demand can drive revenue growth. The U.S. cannabis market is projected to reach $43 billion by 2025. Expanding into new states can be achieved within the next 2-3 years.
- Strategic Partnerships: Forming strategic partnerships with dispensaries and other cannabis companies can enhance Grown Rogue's distribution network and market reach. Collaborating with established players in the industry can provide access to new customers and markets. These partnerships can be established within the next 6-12 months.
- Branding and Marketing: Investing in branding and marketing efforts can help Grown Rogue differentiate itself from competitors and build brand loyalty. Creating a strong brand identity and engaging with consumers through digital marketing and social media can drive sales and increase market share. These branding initiatives can be implemented within the next 3-6 months.
- Focus on Quality and Compliance: Maintaining a strong focus on product quality and regulatory compliance can enhance Grown Rogue's reputation and build trust with consumers. Adhering to strict quality control standards and complying with all applicable regulations can help the company avoid legal issues and maintain its competitive advantage. This ongoing effort is crucial for long-term success.
What Opportunities Does GRUSF Have?
- Expanding into new geographic markets as legalization progresses.
- Developing new and innovative cannabis products.
- Forming strategic partnerships with other cannabis companies.
- Increasing brand awareness through marketing and advertising.
What Threats Does GRUSF Face?
- Stringent and evolving regulations in the cannabis industry.
- Intense competition from other cannabis companies.
- Changing consumer preferences and trends.
- Potential for federal legalization to disrupt the market.
What Are GRUSF's Competitive Advantages?
- Established distribution network through dispensaries.
- Brand recognition in specific regional markets.
- Proprietary cultivation techniques.
- Focus on quality control and compliance.
What Does GRUSF Do?
Grown Rogue International Inc. is a cannabis company that cultivates, manufactures, and distributes a variety of cannabis products in the United States. Headquartered in Medford, Oregon, the company’s offerings include flower products (indicas, sativas, and hybrids), edibles, vape cartridges, pre-rolls, and concentrates. These products are sold through a network of dispensaries. Founded to capitalize on the burgeoning cannabis market, Grown Rogue has strategically positioned itself to cater to diverse consumer preferences within the sector. The company's operations encompass the entire value chain from cultivation to retail distribution, ensuring quality control and brand consistency. Grown Rogue's focus on product innovation and market expansion reflects its commitment to establishing a strong foothold in the competitive cannabis industry. As the regulatory landscape evolves, Grown Rogue continues to adapt its strategies to maintain compliance and pursue growth opportunities. The company's emphasis on quality and customer satisfaction underscores its mission to become a leading player in the cannabis market.
What Products and Services Does GRUSF Offer?
- Cultivates cannabis plants in the United States.
- Manufactures a variety of cannabis products, including flower, edibles, and concentrates.
- Sells its products through a network of dispensaries.
- Offers different strains of flower, such as indicas, sativas, and hybrids.
- Produces vape cartridges and pre-rolls for convenient consumption.
- Distributes its products to retail locations.
How Does GRUSF Make Money?
- Cultivates cannabis plants.
- Processes raw cannabis into various consumer products.
- Distributes products through dispensaries.
- Generates revenue through the sale of cannabis products.
What Industry Does GRUSF Operate In?
Grown Rogue International Inc. operates within the rapidly expanding cannabis industry, which is characterized by increasing legalization and evolving consumer preferences. The market is highly competitive, with numerous players vying for market share. Key trends include the growing demand for diverse cannabis products, such as edibles and concentrates, and the increasing acceptance of cannabis for medicinal and recreational use. Grown Rogue competes with companies like BIOYF, ETST, GGBXF, HSCHF, and IUGNF. The industry is subject to stringent regulations, which vary by state and federal jurisdictions.
Who Are GRUSF's Key Customers?
- Adults aged 21 and over who are legally allowed to purchase cannabis products.
- Patients with medical cannabis cards who use cannabis for therapeutic purposes.
- Recreational cannabis users seeking various consumption methods.
- Dispensaries that retail cannabis products to consumers.
F-Score 7/9Financial Health
Grown Rogue International Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals.
ROE 1%Key Financial Metrics
Return on equity for Grown Rogue International Inc. stands at 1.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.5%, showing how much profit it generates from its asset base. GRUSF trades at a trailing price-to-earnings ratio of 306.62, above the Healthcare sector average of ~23x. Its free cash flow yield is -0.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.99 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.3%, the inverse of the P/E and a quick read on earnings relative to price.
Grown Rogue International Inc. (GRUSF) Valuation Context
Valued at $117.67M, GRUSF is classified as a micro-cap stock. Relative to its peer group, GRUSF's quantitative score of 43/100 is below the peer average of 58/100.
GRUSF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Diverse product offerings (flower, edibles, concentrates).
- Established distribution network through dispensaries.
- Strong profit margin of 28.8%.
- Gross margin of 49.8% indicates efficient operations.
Bear Case
- Small market capitalization of $117.67M.
- High beta of -1.31 suggests volatility.
- Reliance on a single geographic market (United States).
- No dividend yield may deter some investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
GRUSF Latest News
No recent news available for GRUSF.
GRUSF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GRUSF.
Price Targets
Wall Street price target analysis for GRUSF.
GRUSF MoonshotScore
What does this score mean?
The MoonshotScore rates GRUSF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: J. Obie Strickler
CEO
J. Obie Strickler is the CEO of Grown Rogue International Inc. His background includes experience in managing and scaling businesses. He has been involved in the cannabis industry for several years, focusing on cultivation, manufacturing, and distribution. His expertise lies in navigating the complex regulatory landscape and building a strong brand presence. Strickler's leadership is focused on driving growth and innovation within the company. He is responsible for overseeing all aspects of the business, from cultivation to retail sales.
Track Record: Under J. Obie Strickler's leadership, Grown Rogue International Inc. has expanded its product offerings and distribution network. He has overseen the company's growth in the competitive cannabis market. His strategic decisions have focused on maintaining compliance and pursuing growth opportunities. He has also emphasized the importance of quality and customer satisfaction.
GRUSF OTC Market Information
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market, indicating that Grown Rogue International Inc. may not meet the minimum financial reporting standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosures, making it difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight. These companies are not subject to the same listing requirements as those on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases investment risk.
- Lower liquidity can lead to price volatility.
- Higher potential for fraud or manipulation.
- Lack of regulatory oversight compared to listed exchanges.
- Difficulty in obtaining reliable information about the company.
- Verify the company's registration and legal status.
- Assess the company's management team and their experience.
- Review any available financial statements and disclosures.
- Research the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Company has been in operation for several years.
- Presence of a functional website and contact information.
- Publicly available news and press releases.
- Listing on a brokerage platform.
- Active management team.
What Investors Ask About Grown Rogue International Inc. (GRUSF) — Healthcare
What does Grown Rogue International Inc. do?
Grown Rogue International Inc. cultivates, manufactures, and distributes cannabis products in the United States. The company offers a range of flower products, including indicas, sativas, and hybrids, as well as edibles, vape cartridges, pre-rolls, and concentrates. These products are sold through a network of dispensaries. Grown Rogue's business model focuses on vertically integrated operations, encompassing cultivation, processing, and distribution to ensure quality control and brand consistency. The company aims to capitalize on the growing demand for cannabis products in both recreational and medicinal markets.
What do analysts say about GRUSF stock?
As of 2026-03-17, there is no readily available analyst consensus on GRUSF stock. Given its OTC listing and small market capitalization, the company may not be widely covered by analysts. Investors should conduct their own due diligence and consider the risks associated with investing in a small-cap, OTC-listed company. Key valuation metrics include its P/E ratio of 12.53 and profit margin of 28.8%. Growth considerations include its ability to expand into new markets and develop innovative products.
What are the main risks for GRUSF?
The main risks for Grown Rogue International Inc. include stringent and evolving regulations in the cannabis industry, intense competition from other cannabis companies, changing consumer preferences, and the potential for federal legalization to disrupt the market. Additionally, as an OTC-listed company, GRUSF faces risks associated with limited financial disclosure, lower liquidity, and potential for price volatility. Investors should carefully consider these risks before investing in GRUSF.
What are the key factors to evaluate for GRUSF?
Grown Rogue International Inc. (GRUSF) holds an AI score of 43/100 (low). Not financial advice.
How frequently does GRUSF data refresh on this page?
GRUSF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven GRUSF's recent stock price performance?
Grown Rogue International Inc. (GRUSF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product offerings (flower, edibles, concentrates). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GRUSF overvalued or undervalued right now?
Valuing Grown Rogue International Inc. (GRUSF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying GRUSF?
Before investing in Grown Rogue International Inc. (GRUSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC market data may be less reliable than exchange-listed data.